TCANCER Trademark Application - Cancer Diagnostics and Therapeutics

ChangeBridge: Trademarks - Medical Services (Class 044)

Published April 2nd, 2026

Detected April 3rd, 2026

Summary

The USPTO published trademark application TM79437944 for TCANCER covering diagnostic reagents, pharmaceutical preparations, and treatment products for cancer. The application covers chemical reagents for medical diagnosis, diagnostic test kits for cancer detection, and pharmaceutical preparations for cancer treatment and prevention. Third parties have until the opposition deadline to challenge the registration.

View original document View source feed page

What changed

The USPTO published trademark application TM79437944 for TCANCER in International Class 005 (and listed under Class 044 Medical Services in the feed). The goods covered include: chemical reagents for medical diagnosis; diagnostic preparations using T-cell receptors; diagnostic radiopharmaceutical preparations; diagnostic test kits for testing bodily fluids for cancer detection and oncology use; medical diagnostic reagents; pharmaceutical preparations for cancer treatment, prevention, and tumour suppression; and protein arrays for medical diagnosis.

Pharmaceutical companies, diagnostic manufacturers, and healthcare providers should review the published goods to identify any potential conflicts with existing trademarks or ongoing product development. Third parties who believe the registration would cause confusion or damage may file an opposition within the designated period following the April 2, 2026 publication date. The trademark has not yet been registered and remains subject to opposition proceedings.

Source document (simplified)

← USPTO Trademark Applications

TCANCER

Published for Opposition TM79437944 Kind: published Apr 02, 2026

Abstract

Chemical products in the nature of chemical reagents for medical diagnosis; diagnostic preparations for medical use through using t-cell receptors (tcrs); diagnostic preparations for medical use; diagnostic radiopharmaceutical preparations; diagnostic reagents for medical and veterinary use in in vitro diagnosis; diagnostic substances for medical use; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer diagnosis; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, individual medical diagnosis; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, tumour identification; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection in oncology; diagnostic test reagents comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection for veterinary use; indicators for medical diagnosis, namely, diagnostic preparations for medical use in vivo diagnosis; medical diagnostic reagents; medical preparations for the treatment of cancer; pharmaceutical drugs in the nature of preparations for the treatment and prevention of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the treatment and prevention of cancer; pharmaceutical preparations for diagnosis, namely, diagnostic agents for pharmaceutical purposes; pharmaceutical preparations for diagnostic purposes, namely, diagnostic agents for pharmaceutical purposes; pharmaceutical preparations for individual medical diagnosis, namely, diagnostic agents for pharmaceutical purposes; pharmaceutical preparations for medical purposes for the treatment and prevention of cancer; pharmaceutical preparations for medical test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer diagnosis; pharmaceutical preparations for medical test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for individual medical diagnosis in the nature of disease detection of cancer; pharmaceutical preparations for medical test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in oncology for testing of bodily fluids for use in cancer; pharmaceutical preparations for medical test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations, namely, protein arrays for medical diagnosis purposes for the diagnosis of diseases; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating cancer; pharmaceutical products, medical and veterinary preparations, namely, diagnostic preparations for medical or veterinary purposes; pharmaceuticals products for the treatment of cancer; pharmaceutical products for treating cancer; preparations for medical diagnosis, namely, diagnostic preparations for medical use in vivo diagnosis; reactants for medical diagnosis, namely, diagnostic preparations for medical use in in vivo diagnosis; reagents and preparations for use in the nature of diagnostic test reagents for medical purposes; reagents for diagnostic tests for medical use; medical tests and medical test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for profiling, in particu...